Drug-resistant tumour cells lose their drug resistance when exposed to low intensity, low frequency electric pulses for three days. A study published today in the open access journal BMC Cancer reveals that treating drug-resistant tumour cells with electric pulses in vitro restores the cells' ability to take up the anti-cancer drug doxorubicin.
The research group led by Luca Cucullo and Damir Janigro from the Cleveland Clinic Lerner College of Medicine, Ohio, USA exposed rat and human tumour cells to very low intensity (7.5 microamps) 50 Hertz alternating current pulses, with a ten-second interval, for three days in vitro. Such electrical stimulation is known not to damage cells but to decrease the proliferation of tumour cells. The tumour cell lines used overexpress the MDR1 protein, which makes them resistant to anti-cancer drugs such as doxorubicin. Following the three days of electrical stimulation, the cells were exposed to increasing concentrations of doxorubicin for three hours.
Janigro et al.'s results show that electrical stimulation led to an increased uptake of doxorubicin, which caused the cells to die, even at low doxorubicin concentrations. Exposing the cells to an electric current was more effective than treating the cells with an MDR1 inhibitor. These findings suggest the potential application of electrical stimulation to improve the efficacy of existing chemotherapeutic treatments.
Page: 1 Related biology news :1
Contact: Juliette Savin
. Journalists can register now for ECCO 14 -- the European Cancer Conference2
. Cancer cures could work for canines and humans3
. The Cancer Genome Atlas awards funds for technology development4
. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency5
. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents6
. Cancer stem cells can go it alone7
. Cancer drug enhances long-term memory8
. Cancer cells reprogram energy needs to grow and spread, study suggests9
. Cancer scientists create human leukemia process to map how disease begins, progresses10
. Cancer tip -- Nanoparticles can damage DNA, increase cancer risk11
. Other highlights from the April 18 Journal of the National Cancer Institute